Caner Saygin, Leukemologist at The University of Chicago, shared a post on X:
“Jen Cooperrider presenting cool data on how TP53-mutant CH progresses during myeloma therapy.
So proud of our team! ”
Caner Saygin/X
Caner Saygin, Leukemologist at The University of Chicago, shared a post on X:
“Jen Cooperrider presenting cool data on how TP53-mutant CH progresses during myeloma therapy.
So proud of our team! ”